A medical supplies company completes a £30 million pension buy-in with Canada Life as Gateley steers the transaction, reflecting a surge in UK bulk annuity activity
A UK medical supplies company has completed a £30 million (approximately $40 million) pension buy-in — a transaction in which an insurance company takes on responsibility for paying a defined portion of a pension scheme's liabilities in exchange for a premium — with insurer Canada Life. The deal was advised by Gateley Legal, with the firm's pensions team leading the transaction. A buy-in is structurally distinct from a buy-out (in which the pension scheme is fully wound up and all liabilities transferred to the insurer) — in a buy-in, the scheme retains its legal existence but the insurer covers a matched block of pensioner obligations, removing longevity and investment risk from that tranche. The £30 million transaction sits at the smaller end of a UK bulk annuity (insurance industry term for bulk pension risk transfer) market that has been operating at record volumes, driven by improved scheme funding levels following the 2022 rise in gilt (UK government bond) yields. While this is a relatively small individual transaction, it is illustrative of a structural trend: thousands of UK defined benefit (DB) pension schemes — which promise members a fixed income in retirement, as opposed to defined contribution schemes where the outcome depends on investment returns — are now sufficiently well-funded to pursue de-risking transactions. The pipeline of buy-ins and buy-outs has created sustained demand for pensions legal advisory work across the City, with specialist teams at firms including Gateley, Eversheds, and Hogan Lovells competing for mandates across the size spectrum.
Why this matters
UK DB pension de-risking generates pensions, insurance, and corporate advisory work simultaneously. The trustee board of the pension scheme requires independent legal advice; the corporate sponsor requires separate advice on its obligations and any residual contingent liabilities; and the insurer requires transaction structuring and regulatory compliance counsel. The 'why now' driver is structural: improved funding levels across the UK DB universe — estimated at approximately £2 trillion in aggregate liabilities — combined with a hardening insurer capacity constraint are pushing schemes to transact as quickly as possible before pricing deteriorates. For firms like Gateley that have built dedicated pensions practices, this market represents a reliable revenue stream that is largely insulated from M&A and capital markets volatility.
On the Ground
A trainee on a pensions buy-in matter would review the facility agreement schedules and documentation governing the premium payment mechanics, assist with legal opinion coordination where trustees require confirmation of scheme validity, and prepare CP checklist tracking for the regulatory steps required before the policy can be placed.
Interview prep
Soundbite
Thousands of UK DB schemes are now funded well enough to buy out — the insurer capacity constraint, not legal complexity, is the binding limit on market volume.
Question you might get
“What is the legal difference between a pension buy-in and a buy-out, and what are the key protections a scheme's trustee board should seek in a buy-in transaction?”
Full answer
A UK medical supplies company has completed a £30 million pension buy-in with Canada Life, advised by Gateley Legal. This matters commercially because the UK bulk annuity market is processing a record pipeline of de-risking transactions as improved gilt yields have pushed defined benefit scheme funding ratios to levels that make insurance transactions viable at scale. Each transaction requires independent trustee legal advice, sponsor advice, and insurer structuring work — generating multi-party mandates that are competitive across the City. The wider structural trend is that the total UK DB universe represents approximately £2 trillion in liabilities, a large proportion of which is now in or approaching buy-out territory. Firms that have invested in dedicated pensions practices are seeing that investment pay off in a sustained volume of mandates that are uncorrelated with deal market conditions.
Sources
My notes
saved